Current Liabilities Changement Date
AbbVie USD 34.77B 2.53B 2023-09
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Amgen USD 18.39B 1.44B 2023-12
Biogen USD 3.43B 1.59B 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Bluebird Bio USD 158.96M 23.94M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
Heron Therapeutics USD 79.74M 6.98M 2023-09
Intra Cellular Therapies USD 123.54M 20.45M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
J&J USD 44.37B 9.8B 2023-09
Malin Corporation EUR 1.3M 700K 2023-06
Marinus Pharmaceuticals USD 30.56M 4.95M 2023-09
Merck USD 23.09B 300M 2023-09
Minerva Neurosciences USD 3.35M 1.44M 2023-09
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Otsuka Holdings JPY 631.54B 50.62B 2023-09
Ovoca Bio EUR 2.44M 1.1M 2022-06
Pfizer USD 31.14B 3.51B 2023-09
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Revance Therapeutics USD 82.16M 8.08M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



ALKERMES Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.